✦ LIBER ✦

Genetic Abnormalities as Targets for Molecular Therapies in Myelodysplastic Syndromes

✍ Scribed by DANIELA CILLONI; EMANUELA MESSA; FRANCESCA MESSA; SONIA CARTURAN; ILARIA DEFILIPPI; FRANCESCA ARRUGA; VALENTINA ROSSO; RENATA CATALANO; ENRICO BRACCO; PAOLO NICOLI; GIUSEPPE SAGLIO

Book ID: 111482982
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 168 KB
Volume: 1089
Category: Article
ISSN: 0890-6564
DOI: 10.1196/annals.1386.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytoplasmic abnormalities of erythroblas

Cytoplasmic abnormalities of erythroblasts as a marker for ringed sideroblasts in myelodysplastic syndromes

✍ Pilar Acín; L. Florensa; L.L. Andreu; S. Woessner 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB

In vivo imaging of molecular-genetic tar

In vivo imaging of molecular-genetic targets for cancer therapy

✍ Juri Gelovani Tjuvajev; Ronald G Blasberg 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 364 KB

Molecular addresses in blood vessels as

Molecular addresses in blood vessels as targets for therapy

✍ Mikhail Kolonin; Renata Pasqualini; Wadih Arap 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 82 KB

We have isolated several organ-and tumor-homing peptides by using in vivo phage display. This technology involves the screening of peptide libraries in a living animal. The peptides that result from such a selection home to specific organs or tissues because they recognize molecular 'addresses', rec

Vimentin in cancer and its potential as

Vimentin in cancer and its potential as a molecular target for cancer therapy

✍ Arun Satelli; Shulin Li 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 417 KB

Deletion 6p as the sole chromosome abnor

Deletion 6p as the sole chromosome abnormality in a patient with therapy-related myelodysplastic syndrome: case report and review of the literature

✍ Aurelia M. Meloni-Ehrig; Elizabeth Alexander; Sathia V. Nathan; Mohamed S. Ahmed 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Effect of haematological improvement on

Effect of haematological improvement on survival in patients given targeted therapy as initial treatment of acute myeloid leukaemia or high-risk myelodysplastic syndrome

✍ Masamitsu Yanada; Xuelin Huang; Guillermo Garcia-Manero; Susan O'Brien; Farhad R 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB